Investor Presentaiton

Branded Generics Markets - Long term sustainability What is the likelihood of the market escaping price intervention by payers? Assessed through: Limited pressure to reduce healthcare spend Strong desire to support local pharma companies High Higher long-term sustainability Germany France Low Low Brazil India Mexico Russia Algeria Saudi Arabia Romania Turkey Poland South Africa Czech Republic Hungary How strong is the preference for brands? Assessed through: ■ Intrinsic local preference for brands Patients' willingness to pay price premium Lack of confidence in ability of regulatory system to safeguard drug quality Unlocking Pharma growth - Mckinsey High ×

View entire presentation